Shares of Insulet Corp. PODD shed 1.03% to $265.65 Tuesday, on what proved to be an all-around grim trading session for the ...
Investor's Business Daily on MSN20h
Insulin Device Maker Has Analysts Turning Bullish
Insulet stock is near a buy point after gapping up on earnings. The company increased its full year sales guidance.